The global fill finish manufacturing market is projected to grow from USD 18.36 billion in 2025 to USD 28.14 billion by 2030, ...
Antibody treatments for cancer and other diseases are typically delivered intravenously, because of the large volumes that are needed per dose. This means the patient has to go to a hospital for every ...
Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera ...
Infant Bacterial Therapeutics AB (IBT) whose mission is to develop and commercialize pharmaceuticals for diseases affecting premature babies and BioConnection, a leading pharmaceutical Contract Manufa ...
Explore trends before investing – request a sample report today! The UK’s National Health Service (NHS) plays a critical ...
The India Generic Injectable Market is projected to witness significant growth, driven by increasing demand for affordable ...
Retatrutide is an investigational triple agonist developed by Eli Lilly that targets GLP-1, GIP and glucagon receptors, and early trials suggest very strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback